Join the club for FREE to access the whole archive and other member benefits.

Jemma C Hopewell

Professor of Precision Medicine and Epidemiology at Oxford Population Health and current co-chair of CARDIoGRAMplusC4D

Dr. Jemma Hopewell leads a team of genetic epidemiologists, clinical fellows, medical statisticians and bioinformaticians in a programme of research focusing on the use of genetic and clinical trial-based studies to investigate the causes and treatments for cardiovascular disease and arrhythmias. She has particular interests in determining predictors of patient response to therapy, using genetics to improve our understanding of drug targets and disease mechanisms, and genomic characterisation of vascular disease and its risk factors, particularly Lp(a).

Jemma leads and collaborates on numerous projects involving CTSU’s vascular mega-trials (e.g. HPS, SEARCH, THRIVE, REVEAL), large-scale studies and biobanks (e.g. PROCARDIS, UK Biobank), and international consortia (e.g. METASTROKE, CARDIoGRAMplusC4D, GoLEAD, CATCH-ME). She is a member of the Lp(a) Foundation Scientific Advisory Board, of various clinical trial and genetic study Steering and Analysis Committees, and is currently the Chair of METASTROKE (a collaboration of the International Stroke Genetics Consortium), as well as co-ordinating the MSc in Global Health Science Genetic Epidemiology module.


Visit website: https://www.ndph.ox.ac.uk/team/jemma-hopewell

 jemma-hopewell

See also: Academia University of Oxford - Collegiate research university and one of the world's leading universities

Details last updated 31-Jan-2023

Jemma C Hopewell News

Large scale study identifies new risk loci associated with CAD (coronary artery disease)

University of Oxford - 06-Dec-2022

The study outlines a list of genes and genetic variants for future study of common diseases

Read more...